It's temporary. It's very rare for 2 groundbreaking therapies , with equivalent efficacy, to get approved for a large market in such short order. When there is a clear efficacy or safety advantage, this won't happen $gild $enta
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.